|
WO2020242744A1
|
|
Mass spectrometry assay methods for detection of metabolites
|
|
AU2019338183A1
|
|
Mass spectrometry assay method for detection and quantitation of microbiota-related metabolites
|
|
CN112136043A
|
|
Mass spectrometry method for detecting and quantifying liver function metabolites
|
|
WO2019116288A1
|
|
Method for analyzing small molecule components of a complex mixture, and associated apparatus and computer program product
|
|
CN111246942A
|
|
Simplified method for analytical validation of biochemical substances using non-targeted mass spectrometry platform detection
|
|
WO2019067699A1
|
|
Compounds, reagents, and uses thereof
|
|
AU2018254394A1
|
|
Mass spectrometry assay method for detection and quantitation of organic acid metabolites
|
|
CN110494954A
|
|
The synthesis and quantitative analysis of lipid and tocopherol
|
|
AU2017382744A1
|
|
Mass spectrometry assay method for detection and quantitation of kidney function metabolites
|
|
AU2017301949A1
|
|
Compounds, reagents, and uses thereof
|
|
WO2017210097A1
|
|
Mass spectrometry method for detection and quantitation of metabolites
|
|
US2018321267A1
|
|
Automated sample quality assessment
|
|
AU2016206265A1
|
|
Method for Determining Insulin Sensitivity with Biomarkers
|
|
CN107407671A
|
|
Diagnostic method, therapeutic agent and its application
|
|
CN107002113A
|
|
The biomarker of fatty liver and its application method
|
|
CA2965874A1
|
|
System, method and apparatus for determining the effect of genetic variants
|
|
US2016019335A1
|
|
Method, apparatus and computer program product for metabolomics analysis
|
|
AU2015296304A1
|
|
Methods, compositions, and kits for analysis of structurally diverse complex lipids
|
|
WO2015184048A1
|
|
Method for analyzing small molecule components of a complex mixture in a multi-sample process, and associated apparatus and computer program product
|
|
EP3805756A1
|
|
Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment
|
